Common Shares Outstanding: The number of class A shares currently held by investors.
Phio Pharmaceuticals Corp. (PHIO) had Common Shares Outstanding of 4.59M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-2.15M |
|
-- |
|
-- |
|
$2.21M |
|
$-2.21M |
|
$0.06M |
|
$-2.15M |
|
$-2.15M |
|
$-2.15M |
|
$-2.15M |
|
$-2.15M |
|
$-2.15M |
|
$-2.21M |
|
$-2.21M |
|
4.58M |
|
4.58M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$6.85M |
|
$0.00M |
|
$0.01M |
|
$6.85M |
|
$1.25M |
|
-- |
|
-- |
|
$1.25M |
|
$5.60M |
|
$5.60M |
|
$5.60M |
|
|
Common Shares Outstanding |
4.59M |
| Cash Flow Statement Financials | |
$-2.01M |
|
-- |
|
$-0.00M |
|
$8.49M |
|
$6.47M |
|
$-2.02M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.44% |
|
-38.44% |
|
-31.43% |
|
-38.44% |
|
$1.22 |
|
$-0.44 |
|
$-0.44 |
|